Table: Phoenixbio -2021/22 group results

PhoenixBio

13/05/2022 08:00

May 13 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended       Year to       NEXT   
               Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                  LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales            1.32            1.01           1.75        786 mln   
                                (-22.7 pct)    (+32.2 pct)  (+23.2 pct) 
  Operating    loss 167 mln    loss 276 mln      206 mln       41 mln   
  Recurring    loss 127 mln    loss 223 mln      211 mln       40 mln   
  Net
  Net          loss 387 mln    loss 238 mln      198 mln       39 mln   
  EPS        loss 117.50 yen  loss 73.60 yen    60.08 yen    11.97 yen  
  Ann Div          NIL              NIL            NIL                  
  -Q2 Div          NIL              NIL            NIL                  
  -Q4 Div          NIL              NIL            NIL                  
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T